Education
About Us
Working with TipRanks
Follow Us
Medical Developments International Limited (AU:MVP)
ASX:MVP
Total Valuation
Medical Developments International Limited has a market cap or net worth of AU$80.55M. The enterprise value is AU$46.17M.
Market CapAU$80.55M
Enterprise ValueAU$46.17M
Share Statistics
Medical Developments International Limited has 112,658,325 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding112,658,325
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medical Developments International Limited’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 2.90%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)2.90%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee574.35K
Profits Per Employee1.38K
Employee Count68
Asset Turnover0.59
Inventory Turnover1.02
Valuation Ratios
The current PE Ratio of Medical Developments International Limited is 715.0. Medical Developments International Limited’s PEG ratio is -6.86.
PE Ratio715.0
PS Ratio1.65
PB Ratio1.17
Price to Fair Value1.17
Price to FCF-132.97
Price to Operating Cash Flow-15.07
PEG Ratio-6.86
Income Statement
In the last 12 months, Medical Developments International Limited had revenue of 39.06M and earned 94.00K in profits. Earnings per share was 0.00.
Revenue39.06M
Gross Profit29.43M
Operating Income3.07M
Pretax Income168.00K
Net Income94.00K
EBITDA1.67M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -43.00K and capital expenditures -443.00K, giving a free cash flow of -486.00K billion.
Operating Cash Flow-43.00K
Free Cash Flow-486.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Medical Developments International Limited pays an annual dividend of AU$0.019, resulting in a dividend yield of ―
Dividend Per ShareAU$0.019
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.27
52-Week Price Change67.44%
50-Day Moving Average0.65
200-Day Moving Average0.61
Relative Strength Index (RSI)57.72
Average Volume (3m)118.82K
Important Dates
Medical Developments International Limited upcoming earnings date is Feb 19, 2026, TBA (Confirmed).
Last Earnings DateAug 20, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend DateMar 05, 2020
Financial Position
Medical Developments International Limited as a current ratio of 4.54, with Debt / Equity ratio of 3.87%
Current Ratio4.54
Quick Ratio3.33
Debt to Market Cap<0.01
Net Debt to EBITDA-9.47
Interest Coverage Ratio40.97
Taxes
In the past 12 months, Medical Developments International Limited has paid 74.00K in taxes.
Income Tax74.00K
Effective Tax Rate0.44
Enterprise Valuation
Medical Developments International Limited EV to EBITDA ratio is 29.14, with an EV/FCF ratio of -100.37.
EV to Sales1.25
EV to EBITDA29.14
EV to Free Cash Flow-100.37
EV to Operating Cash Flow-1.13K
Balance Sheet
Medical Developments International Limited has AU$17.84M in cash and marketable securities with AU$1.99M in debt, giving a net cash position of AU$15.85M billion.
Cash & Marketable SecuritiesAU$17.84M
Total DebtAU$1.99M
Net CashAU$15.85M
Net Cash Per ShareAU$0.14
Tangible Book Value Per ShareAU$0.42
Margins
Gross margin is 46.44%, with operating margin of 7.87%, and net profit margin of 0.24%.
Gross Margin46.44%
Operating Margin7.87%
Pretax Margin0.43%
Net Profit Margin0.24%
EBITDA Margin4.29%
EBIT Margin0.36%
Analyst Forecast
The average price target for Medical Developments International Limited is AU$0.85, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.85
Price Target Upside18.06% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast17.82%
EPS Growth Forecast―